See also this year's filing and all EDGAR filings for this company.
PDF Report 0001082554_2023_UNITED_THERAPEUTICS_Corp.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001082554, UNITED THERAPEUTICS Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,380,300,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 861,500,000 |
| 3 | remainder_Assets | 1,802,700,000 |
| 4 | LiabilitiesCurrent | 343,200,000 |
| 5 | LiabilitiesNoncurrent | 104,600,000 |
| 6 | remainder_Liabilities | 800,000,000 |
| 7 | CostOfGoodsAndServicesSold | 151,600,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 322,900,000 |
| 10 | remainder_Expenses | 705,400,000 |
| 11 | remainder_Revenues | 1,936,300,000 |
| 12 | remainder_NetIncome | -29,100,000 |
| 13 | remainder_ComprehensiveNetIncome | -32,500,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,044,500,000 |
| 1 | Liabilities | 1,247,800,000 |
| 2 | Expenses | 1,179,900,000 |
| 3 | Revenues | 1,936,300,000 |
| 4 | StockholdersEquity | 4,796,700,000 |
| 5 | NetIncome | 727,300,000 |
| 6 | ComprehensiveNetIncome | 711,050,000 |
| 7 | BaseVar | 5,235,050,000 |
| 8 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
